Authors' reply on aspirin for primary prevention
- PMID: 11159585
- PMCID: PMC1119424
Authors' reply on aspirin for primary prevention
Comment on
-
British Hypertension Society guidelines for hypertension management 1999: summary.BMJ. 1999 Sep 4;319(7210):630-5. doi: 10.1136/bmj.319.7210.630. BMJ. 1999. PMID: 10473485 Free PMC article. No abstract available.
-
Determination of who may derive most benefit from aspirin in primary prevention: subgroup results from a randomised controlled trial.BMJ. 2000 Jul 1;321(7252):13-7. doi: 10.1136/bmj.321.7252.13. BMJ. 2000. PMID: 10875825 Free PMC article. Clinical Trial.
-
Aspirin for primary prevention. Treatment policy should be based on all trial evidence, not subgroup analysis.BMJ. 2000 Dec 9;321(7274):1472. BMJ. 2000. PMID: 11187950 Free PMC article. No abstract available.
References
-
- Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet. 1998;351:1755–1762. - PubMed
-
- Steering Committee of the Physicians' Health Study Research Group. Final report on the aspirin component of the ongoing physicians' health study. N Engl J Med. 1989;321:129–135. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources